ArticleNPJ vaccines2021

A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial.

Leike Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.